← Browse by Condition
Medical Condition

aortic stenosis

Total Trials
11
Recruiting Now
11
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for aortic stenosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — aortic stenosis Clinical Trials

How many clinical trials are currently recruiting for aortic stenosis?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for aortic stenosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for aortic stenosis?
aortic stenosis research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a aortic stenosis clinical trial?
Eligibility criteria for aortic stenosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University 1 trial
Eunpyeong St. Mary's Hospital 1 trial
Insel Gruppe AG, University Hospital Bern 1 trial
Sheba Medical Center 1 trial
China National Center for Cardiovascular Diseases 1 trial

Recruiting Clinical Trials

NCT04454177
Recruiting
SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement
Enrollment
100 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →
NCT06722066
Recruiting
Impact of Aortic Annulus Calcification on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement: SAINT-TAVR Calcium Registry
Enrollment
500 pts
Location
South Korea
Sponsor
Eunpyeong St. Mary's Hospital
View Trial →
NCT06894550
Recruiting
Short-term Exposure to High Altitude in Patients With Asymptomatic Aortic Stenosis
Enrollment
60 pts
Location
Switzerland
Sponsor
Insel Gruppe AG, University Ho...
View Trial →
NCT02023060
Recruiting
Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation
Enrollment
100 pts
Location
Israel
Sponsor
Sheba Medical Center
View Trial →
NCT06743568
Recruiting
Efficacy of Self-expandable and Balloon-expandable Valves in Patients With Ascending Aortic Dilation
Enrollment
100 pts
Location
China
Sponsor
China National Center for Card...
View Trial →
NCT06580158
Recruiting
AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction
Enrollment
2,000 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07420907
Recruiting
Study of the Progression of Chronic Cardiovascular Conditions
Enrollment
5,000 pts
Location
United States
Sponsor
Prolaio
View Trial →
NCT06481137
Recruiting
Reversibility of Cardiac Conduction Disturbances Following TAVI
Enrollment
209 pts
Location
Spain
Sponsor
Institut d'Investigació Biomèd...
View Trial →
NCT07205068
Recruiting
Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and Pre-Closure
Enrollment
100 pts
Location
United States
Sponsor
University of Tennessee Gradua...
View Trial →
NCT04913870 Phase 4
Recruiting
Angiotensin Receptor Blockers in Aortic Stenosis
Enrollment
144 pts
Location
Canada, Denmark
Sponsor
Institut universitaire de card...
View Trial →
NCT07052071
Recruiting
Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis
Enrollment
40 pts
Location
Greece
Sponsor
Hippocration General Hospital
View Trial →

Related Conditions

valvular heart disease (1) transcatheter aortic valve replacement (1) altitude (1) trans catheter aortic valve (1) ascending aortic dilatation (1) diastolic dysfunction (1) cardiovascular disease cvd (1) heart failure (1) aortic stenosis disease (1) hypertension (1) hypertension htn (1) hypertrophic cardiomyopathy patients (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology